Related Experiment Video
Updated: May 17, 2026

Three-Dimensional Culture of Murine Colonic Crypts to Study Intestinal Stem Cell Function Ex Vivo
Published on: October 11, 2022
Tight junction proteins claudin-3 and claudin-4 control tumor growth and metastases
Xiying Shang1, Xinjian Lin, Edwin Alvarez
1Department of Medicine and Moores Cancer Center, University of California, San Diego, La Jolla, CA 92093, USA.
Abstract:
The extent of tight junction (TJ) formation is one of many factors that regulate motility, invasion, and metastasis. Claudins are required for the formation and maintenance of TJs. Claudin-3 (CLDN3) and claudin-4 (CLDN4) are highly expressed in the majority of ovarian cancers. We report here that CLDN3 and CLDN4 each serve to constrain the growth of human 2008 cancer xenografts and limit metastatic potential. Knockdown of CLDN3 increased in vivo growth rate by 2.3-fold and knockdown of CLDN4 by 3.7-fold in the absence of significant change in in vitro growth rate. Both types of tumors exhibited increase in birth rate as measured by Ki67 staining and decrease in death rate as reflected by terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) staining. Knockdown of either claudin did not alter expression of other TJ protein but did reduce TJ formation as measured by transepithelial resistance and paracellular flux of dextran, enhance migration and invasion in in vitro assays, and increase lung colonization following intravenous injection. Knockdown of CLDN3 and CLDN4 increased total lung metastatic burden by 1.7-fold and 2.4-fold, respectively. Loss of either CLDN3 or CLDN4 resulted in down-regulation of E-cadherin mRNA and protein, increased inhibitory phosphorylation of glycogen synthase kinase-3β (GSK-3β), and activation of β-catenin pathway signaling as evidenced by increases in nuclear β-catenin, the dephosphorylated form of the protein, and transcriptional activity of β-catenin/T-cell factor (TCF). We conclude that both CLDN3 and CLDN4 mediate interactions with other cells in vivo that restrain growth and metastatic potential by sustaining expression of E-cadherin and limiting β-catenin signaling.
Insights
Claudin-3 and claudin-4 proteins are crucial for ovarian cancer. Their reduced expression accelerates tumor growth and metastasis by affecting E-cadherin and beta-catenin signaling pathways.
Area of Science:
- Oncology
- Cell Biology
- Cancer Metastasis
Background:
- Tight junction (TJ) formation regulates cancer cell motility, invasion, and metastasis.
- Claudins are essential proteins for TJ formation and maintenance.
- Claudin-3 (CLDN3) and claudin-4 (CLDN4) are highly expressed in most ovarian cancers.
Purpose of the Study:
- To investigate the role of CLDN3 and CLDN4 in constraining ovarian cancer xenograft growth and limiting metastatic potential.
- To elucidate the molecular mechanisms by which CLDN3 and CLDN4 influence cancer progression.
Main Methods:
- Gene knockdown of CLDN3 and CLDN4 in human 2008 cancer xenografts.
- In vivo growth rate and metastatic potential assessment.
- Analysis of cell proliferation (Ki67) and apoptosis (TUNEL).
- Measurement of transepithelial electrical resistance and paracellular flux.
- In vitro migration and invasion assays.
- Western blotting and RT-PCR for E-cadherin, GSK-3β, and β-catenin pathway components.
Main Results:
- CLDN3 and CLDN4 knockdown significantly increased in vivo tumor growth rate (2.3-fold and 3.7-fold, respectively) without affecting in vitro growth.
- Knockdown led to increased cell proliferation and decreased apoptosis in xenografts.
- Reduced TJ integrity, enhanced cell migration and invasion, and increased lung colonization were observed upon claudin knockdown.
- Loss of CLDN3/CLDN4 resulted in decreased E-cadherin expression and activation of the β-catenin signaling pathway.
- Knockdown of CLDN3 and CLDN4 increased lung metastatic burden by 1.7-fold and 2.4-fold, respectively.
Conclusions:
- CLDN3 and CLDN4 constrain ovarian cancer growth and metastasis in vivo.
- These claudins maintain E-cadherin expression and limit β-catenin pathway activation, thereby restricting tumor progression.
- Targeting CLDN3 and CLDN4 may offer therapeutic strategies for ovarian cancer treatment.
Related Concept Videos
Tight Junctions
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
The Tumor Microenvironment
The Tumor Microenvironment
Regulation of Angiogenesis and Blood Supply
Cadherins in Tissue Organization
Cell Sorting During Development
Cell sorting plays an...

